Comparison of incident breast cancer cases in the largest national US tumor registries

Author:

Plichta Jennifer K.123ORCID,Thomas Samantha M.34,Chanenchuk Tori C.1ORCID,Chan Kelley5,Hyslop Terry6,Hwang E. Shelley13,Greenup Rachel A.7

Affiliation:

1. Department of Surgery Duke University Medical Center Durham North Carolina USA

2. Department of Population Health Sciences Duke University Medical Center Durham North Carolina USA

3. Duke Cancer Institute Durham North Carolina USA

4. Department of Biostatistics and Bioinformatics Duke University Durham North Carolina USA

5. American College of Surgeons Cancer Programs Chicago Illinois USA

6. Department of Pharmacology, Physiology and Cancer Biology Thomas Jefferson University Philadelphia Pennsylvania USA

7. Department of Surgery Yale School of Medicine New Haven Connecticut USA

Abstract

AbstractBackgroundThis study compared incident breast cancer cases in the National Cancer Database (NCDB) and Surveillance, Epidemiology, End Results Program (SEER) to a national population cancer registry.MethodsPatients with malignant or in situ breast cancer (BC) 2010–2019 in the NCDB and SEER were compared to the US Cancer Statistics (USCS). Case coverage was estimated as the number of patients in the NCDB/SEER as a proportion of USCS cases.ResultsThe USCS reported 3,047,509 patients; 77.5% patients were included in the NCDB and 46.0% in SEER. Case ascertainment varied significantly by patient sex (both registries, p < .001). For males, 84.1% were captured in the NCDB, whereas only 77.5% of females were included. Case coverage in SEER was better for females than males (46.1% vs. 43.5%). Registries varied significantly by race/ethnicity (both p < .001). Case coverage in the NCDB was highest for non‐Hispanic White (78.2%), non‐Hispanic Black (77.7%), and non‐Hispanic Asian or Pacific Islander (72.5%) BC patients, and lowest for Hispanic (56.4%) and non‐Hispanic American Indian/Alaska Native (41.1%) patients. In SEER, case coverage was highest for non‐Hispanic Asian or Pacific Islander (78.1%) and Hispanic (69.6%) patients and it was significantly lower for all other subgroups (non‐Hispanic Black, 44.8%; non‐Hispanic White, 42.4%; and non‐Hispanic American Indian/Alaska Native, 36.6%).ConclusionsNational US tumor registries provide data for a large sampling of breast cancer patients, yet significant differences in case coverage were observed based on age, sex, and race/ethnicity. These findings suggest that analyses using these data sets and interpretation of findings should account for these meaningful variances.

Funder

National Institutes of Health

Publisher

Wiley

Reference24 articles.

1. Key Statistics for Breast Cancer: How common is breast cancer?Accessed February 9 2023.https://www.cancer.org/cancer/breast‐cancer/about/how‐common‐is‐breast‐cancer.html

2. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer

3. An overview of real‐world data sources for oncology and considerations for research

4. Using the National Cancer Database for Outcomes Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3